Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings
about
A comprehensive overview of targeted therapy in metastatic renal cell carcinomaPrognostic and Predictive Value of DAMPs and DAMP-Associated Processes in CancerHigh molecular weight stress proteins: Identification, cloning and utilisation in cancer immunotherapyTherapeutic cancer vaccines: past, present, and futureRole of vaccine therapy for renal cell carcinoma in the era of targeted therapyHyperthermia as an immunotherapy strategy for cancerOvarian cancer immunotherapy: opportunities, progresses and challengesThe era of bioengineering: how will this affect the next generation of cancer immunotherapy?Translating tumor antigens into cancer vaccinesVitespen: a preclinical and clinical review.HSPPC-96 vaccine in metastatic melanoma patients: from the state of the art to a possible future.Clinical evaluation of therapeutic cancer vaccines.Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma?Vaccination therapy in renal cell carcinoma: current position and future options in metastatic and localized disease.The immunological era in melanoma treatment: new challenges for heat shock protein-based vaccine in the advanced disease.Challenges in the development of an autologous heat shock protein based anti-tumor vaccine.Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases.Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents.Antigen Cross-Presentation and Heat Shock Protein-Based Vaccines.Improving outcomes in high-risk, nonmetastatic renal cancer: new data and ongoing trials.Neuro-oncology biotech industry progress report.Phase II Trial of Adjuvant Immunotherapy with Autologous Tumor-derived Gp96 Vaccination in Patients with Gastric CancerHigh expression of heat shock proteins and heat shock factor-1 distinguishes an aggressive subset of clear cell renal cell carcinoma.Heat shock protein peptide complex-96 vaccination for newly diagnosed glioblastoma: a phase I, single-arm trial.Immunotherapy for renal cell carcinoma
P2860
Q24606852-58F0CEC3-46D1-4ABB-A615-AE7681945056Q26795466-6EA1EE07-AA40-4471-A9B2-7924272EFF34Q26853566-B09BE140-C834-4607-8A5F-0D6BDC91FF00Q26863283-F2EF1836-F3F8-47BB-82F8-5EE0F02C2799Q27016032-1D3CD845-7480-46F1-9781-7B95FA10E57CQ33686985-E9BD0821-DD29-49B3-B333-5D325BA4AC48Q33702218-A7E99F40-3734-47A0-A99E-34B1D0C09A88Q33815087-6E3340CE-0F40-4C59-8BE6-8AA2BA9F69CAQ34484042-52A460C8-1585-411F-A447-2B796E4D81F4Q34996187-17413000-6216-4209-AD99-F4406EDA084DQ35009889-4877F4C4-5583-455E-9FBB-9E222967C876Q37505369-71181D25-CF26-4B80-B88F-A39160829C6CQ37765583-A401973E-3E78-4EFC-9051-3EBD2149C10DQ37892594-F4E46750-F438-48FA-96C0-A87310D06E08Q37908142-37FC5AFA-B7D5-4E16-9373-39F41C96598AQ38031382-00EC980E-3D34-4CB8-B647-032EA34D552CQ38164258-6345C50E-3F68-4E05-9180-31107E3F4B41Q38199545-0C23AC26-25CB-4C61-BE9D-7A599DA84DE4Q38620773-1B52693F-39EC-4D2E-9529-1886095C756DQ38648762-81216608-C51D-459B-831D-D944B5CDF3DDQ38741932-47EBCDA3-8C3F-49C7-B2AC-AA053D50F5A6Q41396108-3E30BE48-2BDE-4F82-8ABF-82A0ADDC96D9Q47855849-278FE8BC-84B7-45E7-A6DE-F1E0AB66FFB9Q53819014-D6278555-3C14-4A73-94C5-C04148721E0CQ58652034-8C4614C1-254B-49C2-99C3-DA5103E93F50
P2860
Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Vaccination of metastatic rena ...... pen vaccine: clinical findings
@ast
Vaccination of metastatic rena ...... pen vaccine: clinical findings
@en
type
label
Vaccination of metastatic rena ...... pen vaccine: clinical findings
@ast
Vaccination of metastatic rena ...... pen vaccine: clinical findings
@en
prefLabel
Vaccination of metastatic rena ...... pen vaccine: clinical findings
@ast
Vaccination of metastatic rena ...... pen vaccine: clinical findings
@en
P2093
P2860
P356
P1476
Vaccination of metastatic rena ...... pen vaccine: clinical findings
@en
P2093
L C Pagliaro
P Srivastava
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604266
P407
P577
2008-03-25T00:00:00Z